We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
JCVI statement setting out advice on the use of the 4CMenB vaccine for the prevention of gonorrhoea in those who are at increased risk of infection.
Interim advice from the JCVI on the requirements for a potential COVID-19 booster vaccination programme for winter 2021 to 2022
Statement setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the spring 2023 COVID-19 vaccination programme.
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the UK government on the use of the coronavirus (COVID-19) Oxford/AstraZeneca vaccine for people aged under 40.
First published during the 2019 to 2022 Johnson Conservative government
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine.
Statement setting out the advice from JCVI on the use of the MVA-BN vaccination for the prevention of mpox.
Using the nasal spray flu vaccine for the UK childhood influenza immunisation programme: advice from JCVI
The Joint Committee on Vaccination and Immunisation (JCVI) is today advising that children at increased risk of serious coronavirus (COVID-19) disease are offered a vaccine.
The Joint Committee on Vaccination and Immunisation has advised that the pneumococcal vaccination programme for those aged 65 years and older should stop.
Conclusions on extending the human papillomavirus infection (HPV) vaccination programme to adolescent boys in the UK.
Sets out JCVI consideration on the number of doses of flu (influenza) vaccine that should be offered to children.
Evidence and considerations for extending the HPV vaccination programme to adolescent boys, from the Joint Committee on Vaccination and Immunisation’s (JCVI).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).